A genetic association study of the CLEC12A gene in rheumatoid arthritis

Joint Bone Spine

Volumn 79, Issue 5, 2012, Pages 451-456

  Michou, Laëtitia ^a   Cornélis, François ^b,c   Levesque, Jean Michel ^a   Bombardieri, Stefano ^d   Balsa, Alejandro ^e   Westhovens, René ^f   Barrera, Pilar ^g   Alves, Helena ^h   van de Putte, Leo ^g   Migliorini, Paola ^d   Bardin, Thomas ⁱ   Petit Teixeira, Elisabeth ^c   Fernandes, Maria J G ^a  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^c UNIVERSITÉ D EVRY VAL D ESSONNE   (France)

^d UNIVERSITY OF PISA   (Italy)

^e HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^f UNIVERSITY OF LEUVEN   (Belgium)

^g RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^h HOSPITAL DE SÃO JOÃO   (Portugal)

ⁱ HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Candidate gene study; CLEC12A gene; Haplotype; Rheumatoid arthritis; Single nucleotide polymorphism

Indexed keywords

CLEC12A PROTEIN; MEMBRANE RECEPTOR; MESSENGER RNA; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; CONTROLLED STUDY; EXON; GENE EXPRESSION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPING TECHNIQUE; HAPLOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; PROMOTER REGION; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; COHORT STUDIES; EUROPE; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HUMANS; LECTINS, C-TYPE; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, MITOGEN;

EID: 84865769297     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2011.12.012     Document Type: Article

References (32)

1. Harris E.D. Pathogenesis of rheumatoid arthritis. Am J Med 1986, 80:4-10.
2. Klareskog L., Padyukov L., Ronnelid J., et al. Genes, environment and immunity in the development of rheumatoid arthritis. Curr Opin Immunol 2006, 18:650-655.
3. Gregersen P.K. Susceptibility genes for rheumatoid arthritis - a rapidly expanding harvest. Bull NYU Hosp Jt Dis 2010, 68:179-182.
4. Stahl E.A., Raychaudhuri S., Remmers E.F., et al. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet 2010, 42:508-514.
5. Etzel C.J., Chen W.V., Shepard N., et al. Genome-wide meta-analysis for rheumatoid arthritis. Hum Genet 2006, 119:634-641.
6. Osorio Y.F.J., Bukulmez H., Petit-Teixeira E., et al. Dense genome-wide linkage analysis of rheumatoid arthritis, including covariates. Arthritis Rheum 2004, 50:2757-2765.
7. Wandstrat A., Wakeland E. The genetics of complex autoimmune diseases: non-MHC susceptibility genes. Nat Immunol 2001, 2:802-809.
8. Yokoyama W.M., Plougastel B.F. Immune functions encoded by the natural killer gene complex. Nat Rev Immunol 2003, 3:304-316.
9. Kanazawa N. Dendritic cell immunoreceptors: C-type lectin receptors for pattern-recognition and signaling on antigen-presenting cells. J Dermatol Sci 2007, 45:77-86.
10. Lorentzen J.C., Flornes L., Eklow C., et al. Association of arthritis with a gene complex encoding C-type lectin-like receptors. Arthritis Rheum 2007, 56:2620-2632.
11. Fujikado N., Saijo S., Yonezawa T., et al. Dcir deficiency causes development of autoimmune diseases in mice due to excess expansion of dendritic cells. Nat Med 2008, 14:176-180.
12. Meyer-Wentrup F., Benitez-Ribas D., Tacken P.J., et al. Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-alpha production. Blood 2008, 111:4245-4253.
13. Han Y., Zhang M., Li N., et al. KLRL1, a novel killer cell lectinlike receptor, inhibits natural killer cell cytotoxicity. Blood 2004, 104:2858-2866.
14. Marshall A.S., Willment J.A., Pyz E., et al. Human MICL (CLEC12A) is differentially glycosylated and is down-regulated following cellular activation. Eur J Immunol 2006, 36:2159-2169.
15. Bakker A.B., van den Oudenrijn S., Bakker A.Q., et al. C-type lectin-like molecule-1: a novel myeloid cell surface marker associated with acute myeloid leukemia. Cancer Res 2004, 64:8443-8450.
16. Chen C.H., Floyd H., Olson N.E., et al. Dendritic-cell-associated C-type lectin 2 (DCAL-2) alters dendritic-cell maturation and cytokine production. Blood 2006, 107:1459-1467.
17. Marshall A.S., Willment J.A., Lin H.H., et al. Identification and characterization of a novel human myeloid inhibitory C-type lectin-like receptor (MICL) that is predominantly expressed on granulocytes and monocytes. J Biol Chem 2004, 279:14792-14802.
18. Galligan C.L., Baig E., Bykerk V., et al. Distinctive gene expression signatures in rheumatoid arthritis synovial tissue fibroblast cells: correlates with disease activity. Genes Immun 2007, 8:480-491.
19. Michou L., Lasbleiz S., Rat A.C., et al. Linkage proof for PTPN22, a rheumatoid arthritis susceptibility gene and a human autoimmunity gene. Proc Natl Acad Sci U S A 2007, 104:1649-1654.
20. Teixeira V.H., Pierlot C., Migliorini P., et al. Testing for the association of the KIAA1109/Tenr/IL2/IL21 gene region with rheumatoid arthritis in a European family-based study. Arthritis Res Ther 2009, 11:R45.
21. Arnett F.C., Edworthy S.M., Bloch D.A., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324.
22. Feng T., Zhu X. Genome-wide searching of rare genetic variants in WTCCC data. Hum Genet 2010, 128:269-280.
23. Spielman R.S., McGinnis R.E., Ewens W.J. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993, 52:506-516.
24. Lathrop G.M. Estimating genotype relative risks. Tissue Antigens 1983, 22:160-166.
25. Haldane J.B. The estimation and significance of the logarithm of a ratio of frequencies. Ann Hum Genet 1956, 20:309-311.
26. Laird N.M., Horvath S., Xu X. Implementing a unified approach to family-based tests of association. Genet Epidemiol 2000, 19:S36-S42.
27. Joyce-Shaikh B., Bigler M.E., Chao C.C., et al. Myeloid DAP12-associating lectin (MDL)-1 regulates synovial inflammation and bone erosion associated with autoimmune arthritis. J Exp Med 2010, 207:579-589.
28. Hakonarson H., Grant S.F., Bradfield J.P., et al. A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene. Nature 2007, 448:591-594.
29. Todd J.A., Walker N.M., Cooper J.D., et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 2007, 39:857-864.
30. Hoppenbrouwers I.A., Aulchenko Y.S., Janssens A.C., et al. Replication of CD58 and CLEC16A as genome-wide significant risk genes for multiple sclerosis. J Hum Genet 2009, 54:676-680.
31. Skinningsrud B., Lie B.A., Husebye E.S., et al. A CLEC16A variant confers risk for juvenile idiopathic arthritis and anti-cyclic citrullinated peptide antibody negative rheumatoid arthritis. Ann Rheum Dis 2010, 69:1471-1474.
32. Bronson P.G., Ramsay P.P., Seldin M.F., et al. A candidate gene study of CLEC16A does not provide evidence of association with risk for anti-CCP-positive rheumatoid arthritis. Genes Immun 2010, 11:504-508.